Six-month risk of Pneumocystis pneumonia following acute cellular rejection: A case-control study in solid organ transplant recipients.

Seyed M Hosseini-MoghaddamMostafa ShokoohiGagandeep SinghAtul D NagpalAnthony M Jevnikar

Published in: Clinical transplantation (2021)

Post-transplant PCP is associated with substantial risk of ICU admission, allograft failure, and mortality. Anti-Pneumocystis prophylaxis for at least 6 months following acute TCMR may reduce the risk.

Keyphrases

respiratory failure
liver failure
mechanical ventilation
aortic dissection
drug induced
intensive care unit
emergency department
extracorporeal membrane oxygenation
cardiovascular events
hepatitis b virus
risk factors
cardiovascular disease
acute respiratory distress syndrome
community acquired pneumonia